Open AccessAnalysis of the variety of effects of the tranquilizer mebicar in experimental and clinical medicine
Author(s) -
I. E. Zimakova,
A. M. Karpov,
T. S. Tagirova,
Regina Salikhova,
A. G. Zhilyaev
Publication year - 1995
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj97048
Subject(s) - tranquilizer , variety (cybernetics) , medicine , pharmacology , computer science , artificial intelligence
The drug mebicar, which gave rise to a new class of chemicals with psychotropic activity - derivatives of bicyclic bisureas, has been experimentally studied for more than 20 years, and clinical experience with its use has been accumulating since 1979. During this short time on the scale of pharmacology, experimental substantiation and clinical confirmation of its effectiveness have been obtained in a number of ways. new indications in various fields of medicine: psychiatry, narcology, cardiology, anesthesiology, neuropathology, gynecology, gerontology, dentistry, sports medicine, etc. The versatility of the therapeutic effects of the drug has created a precedent that attracts the attention of specialists. The question arises about the fundamental possibility of such a variety of therapeutic activity of the drug and the mechanisms for its implementation.